Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2010Journal of Inherited Metabolic Disease

Expanded newborn screening: reducing harm, assessing benefit

View Full Paper
Ask AI
Bookmark
Share

Authors

BWBridget WilckenThe University of Sydney

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bridget Wilcken (2010) studied this question.

synapsesocial.com/papers/6ab0c747299e4e9499add8e8https://doi.org/10.1007/s10545-010-9106-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Screening of Infants and Mortality Due to Neuroblastoma2002 · 356 citations
  2. 2The consequences of extended newborn screening programmes: Do we know who needs treatment?2008 · 36 citations
  3. 3Expanded Newborn Screening: Outcome in Screened and Unscreened Patients at Age 6 Years2009 · 165 citations
  4. 4Mitochondrial fatty acid oxidation defects—remaining challenges2008 · 140 citations
  5. 5Treatment recommendations in long‐chain fatty acid oxidation defects: consensus from a workshop2009 · 225 citations